Certificate under Reg. 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended 30 September 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Ltd has submitted a routine compliance certificate to BSE from its Registrar and Share Transfer Agent (MCS Share Transfer Agent Limited) for the quarter and half year ended 30 September 2025. The certificate confirms that all shares received from depository participants for dematerialisation during the quarter were properly accepted or rejected by the RTA and listed on the stock exchanges. It also confirms that physical share certificates received for dematerialisation were mutilated and cancelled, and the depository's name was recorded as the registered owner in the company's register of members within the required 15-day timeline. This is a standard procedural filing required under SEBI rules and contains no financial or operational information about the company.
No material impact on shareholders or stock price. This is a routine regulatory compliance filing confirming that the company's share dematerialisation process is functioning normally, with no corporate action or business update involved.